l-carnitine treatment of anemia
- 1 April 2003
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 41, S27-S34
- https://doi.org/10.1016/s0272-6386(03)00114-8
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Saving erythropoietin by administering l-carnitine?Nephrology Dialysis Transplantation, 1999
- Addition of L‐carnitine to additive solution‐suspended red cells stored at 4 degrees C reduces in vitro hemolysis and improves in vivo viabilityTransfusion, 1997
- Correlation between Serum Carnitine Levels and Erythrocyte Osmotic Fragility in Hemodialysis PatientsNephron, 1996
- Effects of l-carnitine and its acetate and propionate esters on the molecular dynamics of human erythrocyte membraneBiochimica et Biophysica Acta (BBA) - Biomembranes, 1993
- Effect of Serum Parathyroid Hormone and Bone Marrow Fibrosis on the Response to Erythropoietin in UremiaNew England Journal of Medicine, 1993
- The Response to Recombinant Human Erythropoietin in Patients with the Anemia of End-Stage Renal Disease Is Correlated with Serum Carnitine LevelsNephron, 1991
- Effect of L-carnitine and acetyl-L-carnitibe on the human erythrocyte membrane stability and deformabilityLife Sciences, 1990
- Effects of L-carnitine on sodium transport in erythrocytes from dialyzed uremic patientsKidney International, 1987
- Plasma lipoproteins, liver function and glucose metabolism in haemodialysis patients: lack of effect of L-carnitine supplementationScandinavian Journal of Clinical and Laboratory Investigation, 1985
- The role of L-carnitine in the pathogenesis of cardiomegaly in patients with chronic hemodialysis.Japanese Circulation Journal, 1983